Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Dimitrios Patoulias, Michael Doumas

Clin Mol Hepatol. 2020;26(4):582-583. Published online September 25, 2020

DOI: https://doi.org/10.3350/cmh.2020.0264

View: 3430 Download: 66 Web of Science: 2 Crossref: 2

Jisu Li, Shuping Tong

Clin Mol Hepatol. 2015;21(3):193-199. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.193

View: 8652 Download: 199 Web of Science: 9 Crossref: 10

Jae Eun Park, M.D., Chang Hyeong Lee, M.D., Byung Seok Kim, M.D., Im Hee Shin, Ph.D.

Clin Mol Hepatol. 2010;16(1):66-74. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.66

View: 4667 Download: 89 Crossref: 7

Jung Hwan Yoon , June Sung Lee , Hyo Suk Lee , Chung Yong Kim

Clin Mol Hepatol. 1997;3(3):193-201. Published online January 1, 1970

View: 2105 Download: 14

1 |

Viewed By 5333	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5282	MAFLD: How is it different from NAFLD?
Viewed By 5163	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3876	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3824	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search